Ilan Ganot - 27 Jan 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director
Issuer ticker: SLDB
Reported as of: 27 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2026, 20:07:46 UTC
Prior SEC filing: 06 Jan 2026
Next SEC filing: 06 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot

Key filing fact

Ilan Ganot filed Form 4 for Solid Biosciences Inc. (SLDB) on 02 Feb 2026.

Key facts

This page summarizes Ilan Ganot's Form 4 filing for Solid Biosciences Inc. (SLDB).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 02 Feb 2026, 20:07.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727460 Primary reporting owner

Ganot Ilan

Relationship: Director
Address: C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN
Signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot
Signature date: 02 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDB transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,000
Change %: +86%
Price
Shares after: 32,476
Date: 31 Jan 2026
Ownership: Wife
Footnotes: F1

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 99,297
Date: 27 Jan 2026
Ownership: Direct
Footnotes: F2

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,394
Date: 27 Jan 2026
Ownership: See Footnote 3
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +70,900
Change %
Price: $0.000000
Shares after: 70,900
Date: 29 Jan 2026
Ownership: Wife
Underlying class: Common Stock
Underlying amount: 70,900
Exercise price: $6.60
Footnotes: F4

SLDB transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +35,450
Change %
Price: $0.000000
Shares after: 35,450
Date: 29 Jan 2026
Ownership: Wife
Underlying class: Common Stock
Underlying amount: 35,450
Exercise price
Footnotes: F1, F5

SLDB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -15,000
Change %: -25%
Price: $0.000000
Shares after: 45,000
Date: 31 Jan 2026
Ownership: Wife
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Footnote F2

Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Footnote F3

Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

Footnote F4

This option was granted on January 29, 2026 (the "2026 Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Footnote F5

The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Footnote F6

On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary